| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Articles |
Division of Pediatric Endocrinology, Department of Pediatrics (J.S.P., M.R.B.), Emory University, Atlanta, Georgia 30322; Department of Cell and Molecular Biology (D.L.H.), Tulane University, New Orleans, Louisiana 70118; Department of Anatomy, Tulane University School of Medicine (C.J.P.), New Orleans, Louisiana 70112; and Division of Pediatric Endocrinology, Department of Pediatrics (J.P.W.), Cornell University School of Medicine, New York, New York 10021
Address correspondence and requests for reprints to: John S. Parks, M.D., Ph.D., 2040 Ridgewood Drive, Atlanta, Georgia 30322. E-mail: jparks{at}emory.edu
Basic and translational research achievements over the past 2 decades have disclosed the molecular mechanisms underlying several genetic forms of hypopituitarism. Disorders that are limited to the hypothalamic, pituitary, GH axis are caused by mutations in individual components of that axis. Disorders involving GH and one or more additional pituitary hormones are caused by mutations in the homeodomain transcription factors that direct embryological development of the anterior pituitary gland. Pit-1 has a POU-specific and a POU-homeo DNA-binding domain. The phenotype produced by mutations in the PIT1 gene involves deficiencies of GH, PRL, and TSH. Pituitary glands are either small or normally sized. The PROP1 gene encodes a transcription factor with a single paired-like DNA-binding domain. Persons with inactivating mutations in PROP1 have deficiencies of LH and FSH, as well as GH, PRL, and TSH. Their pituitary glands may be small, normally sized, or extremely large and show suprasellar extension. Pituitary degeneration may produce acquired deficiency of ACTH. Expression of the HESX1 gene precedes expression of PROP1 and PIT1, and it is much more widespread. The protein has a paired-like domain, and it competes with the product of PROP1 for DNA-binding. Homozygosity for inactivating mutations of HESX1 produces a complex phenotype that resembles septo-optic dysplasia. Much more needs to be learned about the role of HESX1 mutations in other forms of hypopituitarism.
This article has been cited by other articles:
![]() |
C. E. Khodr, S. M. Clark, D. L. Hurley, and C. J. Phelps Long-Term, Homologous Prolactin, Administered through Ectopic Pituitary Grafts, Induces Hypothalamic Dopamine Neuron Differentiation in Adult Snell Dwarf Mice Endocrinology, April 1, 2008; 149(4): 2010 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Demarco, T. C. Voss, C. F. Booker, and R. N. Day Dynamic Interactions between Pit-1 and C/EBP{alpha} in the Pituitary Cell Nucleus Mol. Cell. Biol., November 1, 2006; 26(21): 8087 - 8098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Vesper, L. T. Raetzman, and S. A. Camper Role of Prophet of Pit1 (PROP1) in Gonadotrope Differentiation and Puberty Endocrinology, April 1, 2006; 147(4): 1654 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Hu, F. Li, H.-M. Yu, R.-Y. Li, Q.-Y. Ma, T.-J. Ye, Z.-Y. Lu, J.-L. Chen, and H.-D. Song The Mimecan Gene Expressed in Human Pituitary and Regulated by Pituitary Transcription Factor-1 as a Marker for Diagnosing Pituitary Tumors J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6657 - 6664. [Abstract] [Full Text] [PDF] |
||||
![]() |
R A Sporici, J S Hodskins, D M Locasto, L B Meszaros, A L Ferry, A M Weidner, C A Rinehart, J C Bailey, I M Mains, and S E Diamond Repression of the prolactin promoter: a functional consequence of the heterodimerization between Pit-1 and Pit-1 {beta} J. Mol. Endocrinol., October 1, 2005; 35(2): 317 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Phelps Postnatal Regression of Hypothalamic Dopaminergic Neurons in Prolactin-Deficient Snell Dwarf Mice Endocrinology, December 1, 2004; 145(12): 5656 - 5664. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. O. Nasonkin, R. D. Ward, L. T. Raetzman, A. F. Seasholtz, T. L. Saunders, P. J. Gillespie, and S. A. Camper Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice Hum. Mol. Genet., November 15, 2004; 13(22): 2727 - 2735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lee, Y.-S. Zhu, J. J. Cordero, L.-Q. Cai, I. Labour, C. Herrera, and J. Imperato-McGinley Long-Term Growth Hormone Therapy in Adulthood Results in Significant Linear Growth in Siblings with a PROP-1 Gene Mutation J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4850 - 4856. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Walvoord, M. B. Rosenman, and E. A. Eugster Prevalence of Adrenocorticotropin Deficiency in Children with Idiopathic Growth Hormone Deficiency J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5030 - 5034. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bottner, E. Keller, J. Kratzsch, H. Stobbe, J. F. W. Weigel, A. Keller, W. Hirsch, W. Kiess, W. F. Blum, and R. W. Pfaffle PROP1 Mutations Cause Progressive Deterioration of Anterior Pituitary Function including Adrenal Insufficiency: A Longitudinal Analysis J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5256 - 5265. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Voutetakis, M. Argyropoulou, A. Sertedaki, S. Livadas, P. Xekouki, M. Maniati-Christidi, I. Bossis, N. Thalassinos, N. Patronas, and C. Dacou-Voutetakis Pituitary Magnetic Resonance Imaging in 15 Patients with Prop1 Gene Mutations: Pituitary Enlargement May Originate from the Intermediate Lobe J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2200 - 2206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Brinkmeier, M. A. Potok, K. B. Cha, T. Gridley, S. Stifani, J. Meeldijk, H. Clevers, and S. A. Camper TCF and Groucho-Related Genes Influence Pituitary Growth and Development Mol. Endocrinol., November 1, 2003; 17(11): 2152 - 2161. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Cohen, L. E. Cohen, D. Botero, C. Yu, A. Sagar, M. Jurkiewicz, and S. Radovick Enhanced Repression by HESX1 as a Cause of Hypopituitarism and Septooptic Dysplasia J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4832 - 4839. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schausi, C. Tiffoche, and M.-L. Thieulant Regulation of the Intronic Promoter of Rat Estrogen Receptor {alpha} Gene, Responsible for Truncated Estrogen Receptor Product-1 Expression Endocrinology, July 1, 2003; 144(7): 2845 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Keegan and S. A. Camper Mouse knockout solves endocrine puzzle and promotes new pituitary lineage model Genes & Dev., March 15, 2003; 17(6): 677 - 682. [Full Text] [PDF] |
||||
![]() |
J. F. Enwright III, M. A. Kawecki-Crook, T. C. Voss, F. Schaufele, and R. N. Day A PIT-1 Homeodomain Mutant Blocks the Intranuclear Recruitment Of the CCAAT/Enhancer Binding Protein {alpha} Required for Prolactin Gene Transcription Mol. Endocrinol., February 1, 2003; 17(2): 209 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Vieira, M. R. Dias da Silva, J. M. Cerutti, E. Brunner, M. Borges, L. T. Arnaldi, P. Kopp, and J. Abucham Familial Combined Pituitary Hormone Deficiency due to a Novel Mutation R99Q in the Hot Spot Region of Prophet of Pit-1 Presenting as Constitutional Growth Delay J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tajima, T. Hattorri, T. Nakajima, K. Okuhara, K. Sato, S. Abe, J. Nakae, and K. Fujieda Sporadic Heterozygous Frameshift Mutation of HESX1 Causing Pituitary and Optic Nerve Hypoplasia and Combined Pituitary Hormone Deficiency in a Japanese Patient J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 45 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. F. Osorio, S. Marui, A. A. L. Jorge, A. C. Latronico, L. S. S. Lo, C. C. Leite, V. Estefan, B. B. Mendonca, and I. J. P. Arnhold Pituitary Magnetic Resonance Imaging and Function in Patients with Growth Hormone Deficiency with and without Mutations in GHRH-R, GH-1, or PROP-1 Genes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5076 - 5084. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mitchell, P. Q. Thomas, M. R. Zacharin, and I. E. Scheffer Ectopic Posterior Pituitary Lobe and Periventricular Heterotopia: Cerebral Malformations with the Same Underlying Mechanism? AJNR Am. J. Neuroradiol., October 1, 2002; 23(9): 1475 - 1481. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cohen and S. Radovick Molecular Basis of Combined Pituitary Hormone Deficiencies Endocr. Rev., August 1, 2002; 23(4): 431 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Burns and M. M. Matzuk Minireview: Genetic Models for the Study of Gonadotropin Actions Endocrinology, August 1, 2002; 143(8): 2823 - 2835. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Quentien, F. Pitoia, G. Gunz, M.-P. Guillet, A. Enjalbert, and I. Pellegrini Regulation of Prolactin, GH, and Pit-1 Gene Expression in Anterior Pituitary by Pitx2: An Approach Using Pitx2 Mutants Endocrinology, August 1, 2002; 143(8): 2839 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salvatori, X. Fan, P. E. Mullis, A. Haile, and M. A. Levine Decreased Expression of the GHRH Receptor Gene Due to a Mutation in a Pit-1 Binding Site Mol. Endocrinol., March 1, 2002; 16(3): 450 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Brickman, M. Clements, R. Tyrell, D. McNay, K. Woods, J. Warner, A. Stewart, R. S. P. Beddington, and M. Dattani Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders Development, December 15, 2001; 128(24): 5189 - 5199. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Riepe, C.-J. Partsch, O. Blankenstein, H. Monig, R. W. Pfaffle, and W. G. Sippell Longitudinal Imaging Reveals Pituitary Enlargement Preceding Hypoplasia in Two Brothers with Combined Pituitary Hormone Deficiency Attributable to PROP1 Mutation J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4353 - 4357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vallette-Kasic, A. Barlier, C. Teinturier, A. Diaz, M. Manavela, F. Berthezene, P. Bouchard, J. L. Chaussain, R. Brauner, I. Pellegrini-Bouiller, et al. PROP1 Gene Screening in Patients with Multiple Pituitary Hormone Deficiency Reveals Two Sites of Hypermutability and a High Incidence of Corticotroph Deficiency J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4529 - 4535. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bonomi, M. C. Proverbio, G. Weber, G. Chiumello, P. Beck-Peccoz, and L. Persani Hyperplastic Pituitary Gland, High Serum Glycoprotein Hormone {{alpha}}-Subunit, and Variable Circulating Thyrotropin (TSH) Levels as Hallmark of Central Hypothyroidism due to Mutations of the TSH{beta} Gene J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1600 - 1604. [Abstract] [Full Text] |
||||
![]() |
B. Andersen and M. G. Rosenfeld POU Domain Factors in the Neuroendocrine System: Lessons from Developmental Biology Provide Insights into Human Disease Endocr. Rev., February 1, 2001; 22(1): 2 - 35. [Abstract] [Full Text] |
||||
![]() |
P. Q. Thomas, M. T. Dattani, J. M. Brickman, D. McNay, G. Warne, M. Zacharin, F. Cameron, J. Hurst, K. Woods, D. Dunger, et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia Hum. Mol. Genet., January 1, 2001; 10(1): 39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Agarwal, V. Bhatia, S. Cook, and P. Q. Thomas Adrenocorticotropin Deficiency in Combined Pituitary Hormone Deficiency Patients Homozygous for a Novel PROP1 Deletion J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4556 - 4561. [Abstract] [Full Text] |
||||
![]() |
K. W. Sloop, E. C. Walvoord, A. D. Showalter, O. H. Pescovitz, and S. J. Rhodes Molecular Analysis of LHX3 and PROP-1 in Pituitary Hormone Deficiency Patients with Posterior Pituitary Ectopia J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2701 - 2708. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |